You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Economic Aspects of Beta-Blocker Therapy following Myocardial Infarction

Journal of the Royal Society of Medicine

Impact Factor: 10.3 / 5-Year Impact Factor: 14.6

Journal Homepage Submission guidelines

Free access

Research article

First published online April, 1988

Economic Aspects of Beta-Blocker Therapy following Myocardial Infarction

Volume 81, Issue 4

https://doi.org/10.1177/014107688808100424

Abstract

References

1.

Olsson

G.

, Lubsen

J.

, van Es

G-A

, Rehnqvist

N.

Quality of life after myocardial infarction: effect of chronic metoprolol treatment in mortality and morbidity.

Br Med J 1986; 292: 1491–3

2.

Olsson

G.

, Levin

L-å

, Rehnqvist

N.

Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol.

Br Med J 1987; 294: 339–42

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

Health Care Research

Retricted access

Retricted access

Retricted access